Last reviewed · How we verify
Jose Ignacio Martin — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
2 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| US-guided tenotomy with lidocaine | US-guided tenotomy with lidocaine | phase 3 | Local anesthetic | Voltage-gated sodium channels | Pain management | |
| US-guided tenotomy with PRP | US-guided tenotomy with PRP | phase 3 | Orthopedics |
Therapeutic area mix
- Orthopedics · 1
- Pain management · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Ain Shams Maternity Hospital · 1 shared drug class
- Ain Shams University · 1 shared drug class
- Aligarh Muslim University · 1 shared drug class
- Atlantic Health System · 1 shared drug class
- Aultman Health Foundation · 1 shared drug class
- B.P. Koirala Institute of Health Sciences · 1 shared drug class
- Bagcilar Training and Research Hospital · 1 shared drug class
- Abant Izzet Baysal University · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Jose Ignacio Martin:
- Jose Ignacio Martin pipeline updates — RSS
- Jose Ignacio Martin pipeline updates — Atom
- Jose Ignacio Martin pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Jose Ignacio Martin — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/jose-ignacio-martin. Accessed 2026-06-10.